To circumvent the hurdle for efficient treatment of PC, Tang and his co-workers developed a nanoparticle delivery system using cholesterol modified with co-block polymer PAMD encapsulating GEM and siRNA targeted against PLK1 (siPLK1). This evidence concerns the gene PLK1 and pachyonychia congenita.